Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 10Q - When?
I appreciate your analysis but I think you are focusing too much on financial models that do necessarily translate to PTSC. RMBS is an international company traded on the NASDQ, has 15 years of ongoing revenues of $100 to $200 million per year, several tangible products and new technologies. The finacial models you reference do not tell the whole story. I only make my point because I do not want to hear all the doomsdayers when the 10Q comes out if the SP does not take off. I reiterate my belief in the long term value of PTSC regardless of what happens to the SP after the 10Q and think the focus should be on the M&A so we dont loose investors or confidence in the long term value of this company which is tremendous.
Share
New Message
Please login to post a reply